Next-Level
Intravascular Lithotripsy
FastWave Artero
TM
Advanced IVL for Peripheral Artery Disease
FastWave Sola
TM
Next-Gen IVL for Coronary Artery Disease
Next-Level
Intravascular Lithotripsy
FastWave Artero
TM
Advanced IVL for Peripheral Artery Disease
FastWave Sola
TM
Next-Gen IVL for Coronary Artery Disease
FastWave Artero
TM
Advanced IVL for
Peripheral Artery Disease
FastWave Sola
TM
Next-Gen IVL for
Coronary Artery Disease
As Featured In
Our fast-moving team is developing intravascular lithotripsy (IVL) systems for calcific artery disease, a huge unmet need for patients, and a market valued at over $10B.
Our fast-moving team is developing intravascular lithotripsy (IVL) systems for calcific artery disease, a huge unmet need for patients, and a market valued at over $10B.
Our fast-moving team is developing intravascular lithotripsy (IVL) systems for calcific artery disease, a huge unmet need for patients, and a market valued at over $10B.
IVL Systems Designed for
Today’s Interventionalist
Balloon catheter platform designed for challenging anatomy.
Easy-to-use system with valuable procedural feedback.
Easy-to-use system with valuable procedural feedback.
Easy-to-use system with valuable procedural feedback.
Predictable sonic output with increased pulse availability.
Predictable sonic output with increased pulse availability.
Predictable sonic output with increased pulse availability.
IVL Systems Designed for
Today’s Interventionalist
Balloon catheter platform designed for challenging anatomy.
Easy-to-use system with valuable procedural feedback.
Predictable sonic output with increased pulse availability.
See What the Experts Say
"FastWave’s IVL platforms show incredible promise for calcific disease."
Dr. Art Lee
Interventional Cardiologist
"IVL is a phenomenal therapy and FastWave’s systems are very impressive."
Dr. Peter Schneider
Vascular Surgeon
"I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."
Dr. Amir Kaki
Interventional Cardiologist
"FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."
Dr. Miguel Montero-Baker
Vascular Surgeon
"FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."
Dr. Venkatesh Ramaiah
Vascular Surgeron
"I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."
Dr. Raj Dave
Interventional Cardiologist
"FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."
Dr. William Nicholson
Interventional Cardiologist
"FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."
Dr. Kathleen Kearney
Interventional Cardiologist
"FastWave’s IVL platforms show incredible promise for calcific disease."
Dr. Art Lee
Interventional Cardiologist
"IVL is a phenomenal therapy and FastWave’s systems are very impressive."
Dr. Peter Schneider
Vascular Surgeon
"I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."
Dr. Amir Kaki
Interventional Cardiologist
"FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."
Dr. Miguel Montero-Baker
Vascular Surgeon
"FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."
Dr. Venkatesh Ramaiah
Vascular Surgeron
"I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."
Dr. Raj Dave
Interventional Cardiologist
"FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."
Dr. William Nicholson
Interventional Cardiologist
"FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."
Dr. Kathleen Kearney
Interventional Cardiologist
"FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."
Dr. Kathleen Kearney
Interventional Cardiologist
"FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."
Dr. Miguel Montero-Baker
Vascular Surgeon
"I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."
Dr. Raj Dave
Interventional Cardiologist
"FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."
Dr. Venkatesh Ramaiah
Vascular Surgeron
"IVL is a phenomenal therapy and FastWave’s systems are very impressive."
Dr. Peter Schneider
Vascular Surgeon
"FastWave’s IVL platforms show incredible promise for calcific disease."
Dr. Art Lee
Interventional Cardiologist
"I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."
Dr. Amir Kaki
Interventional Cardiologist
"FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."
Dr. William Nicholson
Interventional Cardiologist
"FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."
Dr. Kathleen Kearney
Interventional Cardiologist
"FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."
Dr. Miguel Montero-Baker
Vascular Surgeon
"I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."
Dr. Raj Dave
Interventional Cardiologist
"FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."
Dr. Venkatesh Ramaiah
Vascular Surgeron
"IVL is a phenomenal therapy and FastWave’s systems are very impressive."
Dr. Peter Schneider
Vascular Surgeon
"FastWave’s IVL platforms show incredible promise for calcific disease."
Dr. Art Lee
Interventional Cardiologist
"I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."
Dr. Amir Kaki
Interventional Cardiologist
"FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."
Dr. William Nicholson
Interventional Cardiologist
"I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."
Dr. Amir Kaki
Interventional Cardiologist
"FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."
Dr. Venkatesh Ramaiah
Vascular Surgeron
"I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."
Dr. Raj Dave
Interventional Cardiologist
"IVL is a phenomenal therapy and FastWave’s systems are very impressive."
Dr. Peter Schneider
Vascular Surgeon
"FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."
Dr. Kathleen Kearney
Interventional Cardiologist
"FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."
Dr. Miguel Montero-Baker
Vascular Surgeon
"FastWave’s IVL platforms show incredible promise for calcific disease."
Dr. Art Lee
Interventional Cardiologist
"FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."
Dr. William Nicholson
Interventional Cardiologist
See What the Experts Say
"FastWave’s IVL platforms show incredible promise for calcific disease."
Dr. Art Lee
Interventional Cardiologist
"IVL is a phenomenal therapy and FastWave’s systems are very impressive."
Dr. Peter Schneider
Vascular Surgeon
"I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."
Dr. Amir Kaki
Interventional Cardiologist
"FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."
Dr. Miguel Montero-Baker
Vascular Surgeon
"FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."
Dr. Venkatesh Ramaiah
Vascular Surgeron
"I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."
Dr. Raj Dave
Interventional Cardiologist
"FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."
Dr. William Nicholson
Interventional Cardiologist
"FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."
Dr. Kathleen Kearney
Interventional Cardiologist
"FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."
Dr. Kathleen Kearney
Interventional Cardiologist
"FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."
Dr. Miguel Montero-Baker
Vascular Surgeon
"I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."
Dr. Raj Dave
Interventional Cardiologist
"FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."
Dr. Venkatesh Ramaiah
Vascular Surgeron
"IVL is a phenomenal therapy and FastWave’s systems are very impressive."
Dr. Peter Schneider
Vascular Surgeon
"FastWave’s IVL platforms show incredible promise for calcific disease."
Dr. Art Lee
Interventional Cardiologist
"I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."
Dr. Amir Kaki
Interventional Cardiologist
"FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."
Dr. William Nicholson
Interventional Cardiologist
"I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."
Dr. Amir Kaki
Interventional Cardiologist
"FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."
Dr. Venkatesh Ramaiah
Vascular Surgeron
"I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."
Dr. Raj Dave
Interventional Cardiologist
"IVL is a phenomenal therapy and FastWave’s systems are very impressive."
Dr. Peter Schneider
Vascular Surgeon
"FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."
Dr. Kathleen Kearney
Interventional Cardiologist
"FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."
Dr. Miguel Montero-Baker
Vascular Surgeon
"FastWave’s IVL platforms show incredible promise for calcific disease."
Dr. Art Lee
Interventional Cardiologist
"FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."
Dr. William Nicholson
Interventional Cardiologist
FastWave’s IVL Platforms Deliver
Promising Early Results
Peripheral Clinical Evidence
Explore case studies showcasing the impact of our IVL technology in patients with calcified peripheral artery disease.
Coronary Clinical Evidence
Learn more about FastWave’s pre-clinical data and feasibility study for patients with calcified coronary artery disease.
FastWave’s IVL Platforms Deliver
Promising Early Results
Peripheral Clinical Evidence
Explore case studies showcasing the impact of our IVL technology in patients with calcified peripheral artery disease.
Coronary Clinical Evidence
Learn more about FastWave’s pre-clinical data and feasibility study for patients with calcified coronary artery disease.
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Meet Our Team
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
Scott Nelson
Co-Founder and CEO
Tristan Tieso
COO
Sukanya Iyer
Head of Technology
Anindita Sengupta
Head of QA/RA
Trent Mengel
Head of Clinical
Lauren Fischer
Program Director
Curt Goreham-Voss, PhD
Principal Engineer
Brady Hatcher
Co-Founder and Director
JC Sun, PhD, MBA
Co-Founder and Director
1 in 4 deaths in the U.S.
is caused by CAD.¹
Every year, CAD causes 17.8 million deaths globally.¹
A limb is amputated every
3-5 minutes in the U.S.²
1 in 2 patients die from
amputation within 1 year.³
Empowering Physicians with Advanced Tools
for Calcific Artery Disease
1 in 4 deaths in the U.S.
is caused by CAD.¹
Every year, CAD causes 17.8 million deaths globally.¹
A limb is amputated every
3-5 minutes in the U.S.²
1 in 2 patients die from
amputation within 1 year.³
See Why Everyone is Talking
About FastWave
See Why Everyone is Talking
About FastWave
Learn About Intravascular Lithotripsy
Learn About Intravascular Lithotripsy
Invest in the Future of IVL
We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.
$50M+ raised from corporate venture, VC, and KOLs.
Successful peripheral and coronary FIH procedures.
Only market incumbent acquired in 2024 by J&J for $13B.
8 patents granted by the USPTO and multiple FTOs.
Invest in the Future of IVL
We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.
$50M+ raised from corporate venture, VC, and KOLs.
Successful peripheral and coronary FIH procedures.
Only market incumbent acquired in 2024 by J&J for $13B.
8 patents granted by the USPTO and multiple FTOs.
Invest in the Future of IVL
We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.
$50M+ raised from corporate venture, VC, and KOLs.
Successful peripheral and coronary FIH procedures.
Only market incumbent acquired in 2024 by J&J for $13B.
8 patents granted by the USPTO and multiple FTOs.
Invest in the Future of IVL
We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.
$50M+ raised from corporate venture, VC, and KOLs.
Successful peripheral and coronary FIH procedures.
Only market incumbent acquired in 2024 by J&J for $13B.
8 patents granted by the USPTO and multiple FTOs.
Follow FastWave's Journey
Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.
© 2025 FastWave Medical Inc.
FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.
Follow FastWave's Journey
Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.
© 2025 FastWave Medical Inc.
FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.
Follow FastWave's Journey
Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.
© 2025 FastWave Medical Inc.
FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.
Follow FastWave's Journey
Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.
© 2025 FastWave Medical Inc.
FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.